Last reviewed · How we verify

NCT03620812

Influence of Rapeseed Proteins on the Postprandial Metabolic Response

Completed NA Last updated 19 May 2020
What this trial tests

NA trial testing rapeseed or soy protein or no protein in Health, Subjective in 20 participants. Completed in 15 December 2019.

Timeline
16 August 2018
Primary endpoint
6 April 2019
15 December 2019

Quick facts

Lead sponsorMartin-Luther-Universität Halle-Wittenberg
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment20
Start date16 August 2018
Primary completion6 April 2019
Estimated completion15 December 2019
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Martin-Luther-Universität Halle-Wittenberg — full company profile →

Who can join

Adults 18 to 65, any sex, with Health, Subjective. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to investigate the effect of rapeseed proteins on the postprandial metabolic response. Therefore, study participants will receive a meal rich in fat and carbohydrates with and without rapeseed protein or with soy protein that serves as control.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Postprandial Metabolic Response to Rapeseed Protein in Healthy Subjects.
    Volk C, Brandsch C, Schlegelmilch U, Wensch-Dorendorf M, et al · · 2020 · cited 9× · PMID 32751170 · DOI 10.3390/nu12082270

Verify or expand the search:

Other recruiting trials for Health, Subjective

Currently open trials in the same condition.

Other Martin-Luther-Universität Halle-Wittenberg trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03620812.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing